OfficeHours

OCTOBER 23, 2023

However, for private equity investors, this uncertainty represents a unique opportunity to take advantage of investment opportunities in public markets. A “take-private” transaction in the context of private equity is a process by which a PE firm acquires a publicly listed company and converts it into a privately held entity.

Investors 130

Investors Private Equity Equities Investment 130

Growth Business

JULY 17, 2024

Venture capitalists Venture capital is finance provided for an equity stake in a potentially high growth company, and is behind some of the best know and most innovative businesses in the UK such as Pizza Express, Centre Parcs, Odeon, UCI cinemas and Spotify. More on venture capital backing How do you know it’s time to raise venture capital?

Funds 97

Funds Business Finance Finance 97

Devensoft

AUGUST 21, 2023

In the fast-paced world of mergers and acquisitions (M&A), two titans of finance go head-to-head: venture capitalists and private equity firms. On the other side of the ring, private equity firms are focused on acquiring established businesses, restructuring them, and driving operational efficiencies to maximize returns.

Private Equity 52

Private Equity M&A Equities Mergers and Acquisitions 52

Cooley M&A

OCTOBER 29, 2020

is the increased frequency at which SPAC IPOs are occurring. As reflected in Chart 1 , 102 SPAC IPOs have been announced this year as of September 18, 2020—almost double the number of SPAC IPOs in all of last year (and more than double the number of SPAC IPOs in 2018). SPAC vs. IPO. A distinct feature of SPAC 3.0

M&A 52

M&A IPO Valuation Mergers and Acquisitions 52

Focus Investment Banking

FEBRUARY 25, 2024

First, there’s the ability to raise substantial capital by issuing shares to the public in an initial public offering (IPO), as well as secondary offerings. The upshot is that private companies could now raise all the money they needed from private equity or venture capital funds without even considering an IPO.

Private Equity 52

Private Equity IPO Equities Public Trading 52

Sun Acquisitions

SEPTEMBER 16, 2024

Their insights and experience can help navigate regulatory requirements, negotiate favorable terms, and optimize the financial outcome of the transaction. Common exit strategies include selling to strategic buyers, private equity firms, management buyouts (MBOs), or going public through an initial public offering (IPO).

Negotiation 59

Negotiation Business Sale Management 59

Cooley M&A

SEPTEMBER 16, 2022

There are compelling rationales for adopting a dual-class structure, but even proponents of the structure generally acknowledge that these benefits are significantly mitigated once the dual-class shares are out of the hands of the founders and/or pre-IPO stockholders. Potential carve outs for M&A voting agreements. Stockholder litigation.

M&A 59

M&A IPO Shares Mergers and Acquisitions 59

Cooley M&A

MARCH 22, 2023

Structuring In an ideal scenario, you agree exclusivity with the US company to negotiate a smooth and fast deal, but we often see reverse mergers in the context of an auction process where the US public company is hotly looking for an entity to merge with and is in discussions with multiple targets at the same time.

Mergers 52

Mergers IT Mergers and Acquisitions IPO 52

Peak Frameworks

SEPTEMBER 19, 2023

For example, in the 2012 Facebook IPO, common shareholders gained exposure to the tech giant's fortunes, while also securing a say in corporate matters. If you're interested in breaking into finance, check out our , Private Equity Course and , Investment Banking Course , which help thousands of candidates land top jobs every year.

Corporation 52

Corporation Private Equity Mergers and Acquisitions Corporate Finance 52

Mergers and Inquisitions

SEPTEMBER 20, 2023

Q: Why not private equity, growth equity, hedge funds, or entrepreneurship? Growth equity is a bit closer, but you’re more interested in early-stage companies that need VC support rather than already successful companies that need more capital. Q: Tell me about the current IPO, M&A, and VC funding markets.

Capital 59

Capital Valuation Investment Portfolio 59

Cooley M&A

JANUARY 20, 2022

While R&W insurance has been a staple for private equity buyers for several years, the increased adoption of R&W insurance by strategic acquirers in acquisitions of private targets is a notable trend – almost 30% of all R&W policies in 2021 were procured by strategic buyers. [1].

M&A 40

M&A Insurance Mergers and Acquisitions IPO 40

Cooley M&A

APRIL 5, 2024

Public companies and companies contemplating an IPO are in a trickier situation. It has been common market practice for founders, private equity sponsors and other controlling stockholders to retain governance rights over a controlled company after an IPO, often through a stockholder agreement with the IPO issuer.

M&A 52

M&A Mergers and Acquisitions Mergers Corporation 52

Cooley M&A

JANUARY 25, 2023

Although there were 104 initial public offerings of biotechnology companies in 2021 that raised nearly $15 billion in funds, 2022 saw only 22 such IPOs collectively raising less than $2 billion. Let’s dig in. Activists may be able to take advantage of high trading volumes to accumulate positions without early detection.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

Cooley M&A

NOVEMBER 1, 2018

government shutdown disrupting the market for IPOs, Brexit uncertainty, natural disasters and various other crises, cross-border M&A activity momentum continues. In what remains largely a low organic growth environment, deals were being funded by the record levels of dry powder held by private equity and cash piles repatriated by U.S.

M&A 52

M&A Mergers and Acquisitions Government Business 52

Cooley M&A

JANUARY 20, 2022

2021’s SPAC activity was most intense in the first quarter, with 298 SPAC IPOs priced and 97 deSPAC transactions announced in the first quarter alone. These divestiture transactions often result in new, leaner players with extra cash to fund future operational and strategic objectives. time highs in 2021.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Mergers 40

Cooley M&A

JANUARY 25, 2023

However, deal activity fizzled in the second half of 2022, as high inflation, aggressive anti-inflation monetary policies, geopolitical instability, assertive antitrust regulators and tightening financing markets depressed target valuations, reduced strategic acquirer confidence and sidelined private equity sponsor buyers. trillion. [2]

M&A 52

M&A Mergers and Acquisitions Private Equity Mergers 52

Cooley M&A

FEBRUARY 15, 2017

Dealmakers appear much more optimistic in the first quarter of 2017 than at this same time last year, in part because of greater optimism about the IPO market and the potential for favorable corporate tax and other regulatory changes. Negotiating Anti-Reliance Language. Innovation Pressures Fuel M&A. Appraisal Risks Factor High.

M&A 40

M&A IPO Pharmaceutical Valuation 40

Cooley M&A

FEBRUARY 3, 2025

Over the course of the year, many of the headwinds that have slowed tech M&A activity since 2022 began to abate as interest rates moderated, the acquisition financing market returned and equity markets reached new highs. billion acquisition of Altair, IBMs pending $6.4 billion acquisition of HashiCorp and a Permira-led consortiums $6.9

M&A 59

M&A Mergers and Acquisitions Private Equity Acquisitions 59